Tissue Oxygenation and Cerebral Vulnerability to Hypoxia

组织氧合和大脑缺氧的脆弱性

基本信息

  • 批准号:
    8418707
  • 负责人:
  • 金额:
    $ 18.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-02-15 至 2015-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The longterm goal of these studies is to understand the physiological consequences of global cerebral hypoxia, and how failure of the normal homeostatic mechanisms contributes to cerebral disease. The human brain has a high energy demand and a low tolerance for interruptions of oxygen availability. Our overall hypothesis is that any lowering of tissue oxygenation (PtO2) leads to a progressive deterioration of the health of the brain, rather than impairment only when PtO2 reaches very low threshold levels. If true, this idea has implications for the management and treatment of a wide range of conditions causing brain injury that have a hypoxic component to them. The critical factor that determines injury in this scenario is the degree to which tissue oxygenation decreases. Testing this overall hypothesis in humans is chalenging; the normal physiological responses are altered once hypoxic injury has occurred, thus we need a physiological model of tissue hypoxia without concomitant disease. During our recent studies investigating cerebral acclimatization to high altitude in human subjects, we found that Cerebral O2 metabolism (CMRO2) increases during hypoxia despite reduced O2 availability. Since tisue PtO2 is directly impacted by cerebral blood flow (CBF) (supplying O2) and CMRO2 (removing O2), this paradoxical mismatch of O2 supply and demand has the potential to manipulate PtO2 and thus to test our overall hypothesis of the central role of PtO2 in determining cerebral vulnerability to hypoxia. Our goal in this project is o use novel MRI techniques to measure CBF, CMRO2 and PtO2 to test the influence of PtO2 on cerebral susceptibility to hypoxia in human subjects. Our first Specific Aim is to examine the role of arterial PaCO2 to explain the increase of CMRO2 during acute hypoxic exposure. We wil test how high, normal and low CO2 during normoxic and hypoxic conditions impact CMRO2. Our second Specific Aim is to test if subjects vulnerable to hypoxic cerebral ilnes (manifest as susceptibility to acute mountain sickness - AMS) show a greater drop in tissue PtO2 on exposure to hypoxia conditions than AMS-resistant subjects. This series of studies will test our model of paradoxical CMRO2 response to hypoxia as a means to influence tissue oxygenation, and from this determine the importance of high tissue oxygenation for conferring resistance to cerebral hypoxic disease
描述(由申请方提供):这些研究的长期目标是了解全脑缺氧的生理后果,以及正常稳态机制的失效如何导致脑疾病。人类大脑具有高能量需求和对氧气供应中断的低耐受性。我们的总体假设是,组织氧合(PtO 2)的任何降低都会导致大脑健康的逐步恶化,而不是只有当PtO 2达到非常低的阈值水平时才受到损害。如果属实,这一想法将对管理和治疗多种导致脑损伤且含有缺氧成分的疾病产生影响。在这种情况下,决定损伤的关键因素是组织氧合降低的程度。在人类中测试这一整体假设是具有挑战性的;一旦发生缺氧损伤,正常的生理反应就会改变,因此我们需要一个没有伴随疾病的组织缺氧生理模型。在我们最近的研究中,我们发现,脑氧代谢(CMRO 2)增加,尽管减少氧气供应的高海拔地区的人类受试者的大脑习服。由于组织PtO 2直接受到脑血流量(CBF)(提供O2)和CMRO 2(去除O2)的影响,这种O2供需矛盾的不匹配有可能操纵PtO 2,从而检验我们关于PtO 2在确定脑缺氧脆弱性中的核心作用的总体假设。本研究的目的是利用新的MRI技术测量脑血流量(CBF)、CMRO_2和PtO_2,以检测PtO_2对人类受试者大脑缺氧敏感性的影响。我们的第一个具体目标是检查角色 的动脉PaCO 2解释急性缺氧暴露期间CMRO 2的增加。我们将测试在常氧和低氧条件下高、正常和低CO2对CMRO 2的影响。我们的第二个具体目标是测试易患缺氧性脑病的受试者(表现为对急性高山病的易感性- AMS)在暴露于缺氧条件时是否比AMS抵抗受试者显示出更大的组织PtO 2下降。这一系列的研究将测试我们的CMRO 2对缺氧的反常反应模型作为影响组织氧合的手段,并由此确定高组织氧合对于赋予对脑缺氧疾病的抵抗力的重要性

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID DUBOWITZ其他文献

DAVID DUBOWITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID DUBOWITZ', 18)}}的其他基金

Cerebral Diffusion: A new approach to sleep disorders
脑扩散:治疗睡眠障碍的新方法
  • 批准号:
    9372571
  • 财政年份:
    2017
  • 资助金额:
    $ 18.7万
  • 项目类别:
MRI of cerebral metabolic reactivity
脑代谢反应性MRI
  • 批准号:
    9036263
  • 财政年份:
    2015
  • 资助金额:
    $ 18.7万
  • 项目类别:
Hemodynamic and Metabolic Coupling in Migraine
偏头痛的血流动力学和代谢耦合
  • 批准号:
    8624417
  • 财政年份:
    2013
  • 资助金额:
    $ 18.7万
  • 项目类别:
Hemodynamic and Metabolic Coupling in Migraine
偏头痛的血流动力学和代谢耦合
  • 批准号:
    8730250
  • 财政年份:
    2013
  • 资助金额:
    $ 18.7万
  • 项目类别:
Tissue Oxygenation and Cerebral Vulnerability to Hypoxia
组织氧合和大脑缺氧的脆弱性
  • 批准号:
    8303023
  • 财政年份:
    2012
  • 资助金额:
    $ 18.7万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    7437279
  • 财政年份:
    2007
  • 资助金额:
    $ 18.7万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    8074491
  • 财政年份:
    2007
  • 资助金额:
    $ 18.7万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    7615700
  • 财政年份:
    2007
  • 资助金额:
    $ 18.7万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    7844995
  • 财政年份:
    2007
  • 资助金额:
    $ 18.7万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    7261041
  • 财政年份:
    2007
  • 资助金额:
    $ 18.7万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 18.7万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了